VirtualScopics, Inc. is a provider of imaging services serving the pharmaceutical and biotechnology industries in early and late-stage clinical trials. The Company offers a range of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its image-based measurement and visualization tools enable reproducible measurement of minute changes that occur in anatomic structures in oncology, cardiology, neurology and musculoskeletal diseases. It has developed a system which enables the assessment of oncology patients per standard Response Evaluation Criteria in Solid Tumors criteria, while permitting the measurement of measures, including tumor volume, tumor metabolic rate through fluorodeoxyglucose-positron emission tomography and tumor mitotic rate through fluorodeoxyglucose-positron emission tomography or tumor cellular density through diffusion magnetic resonance imaging.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Advanced Medical Equipment & Technology - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:VSCP
- CUSIP: N/A
- Web: www.virtualscopics.com/
- 50 Day Moving Avg: $4.05
- 200 Day Moving Avg: $3.54
- 52 Week Range: $1.73 - $6.65
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Net Margins: -13.10%
- Return on Equity: -61.91%
- Return on Assets: -28.44%
- Average Volume: 28,768 shs.
Frequently Asked Questions for VirtualScopics (NASDAQ:VSCP)
What is VirtualScopics' stock symbol?
VirtualScopics trades on the NASDAQ under the ticker symbol "VSCP."
How were VirtualScopics' earnings last quarter?
VirtualScopics Inc (NASDAQ:VSCP) issued its earnings results on Thursday, October, 29th. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $3.22 million for the quarter, compared to analysts' expectations of $2.74 million. VirtualScopics had a negative net margin of 13.10% and a negative return on equity of 61.91%. View VirtualScopics' Earnings History.
Who are some of VirtualScopics' key competitors?
Some companies that are related to VirtualScopics include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Boston Scientific Corporation (BSX), Koninklijke Philips N.V. (PHG), Intuitive Surgical (ISRG), Illumina (ILMN), Edwards Lifesciences Corporation (EW), Cerner Corporation (CERN), Agilent Technologies (A), Waters Corporation (WAT), Hologic (HOLX), ResMed (RMD), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR) and Accelerate Diagnostics (AXDX).
How do I buy VirtualScopics stock?
Shares of VirtualScopics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is VirtualScopics' stock price today?
MarketBeat Community Rating for VirtualScopics (NASDAQ VSCP)MarketBeat's community ratings are surveys of what our community members think about VirtualScopics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of VirtualScopics stock can currently be purchased for approximately $4.04.
Consensus Ratings for VirtualScopics (NASDAQ:VSCP) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for VirtualScopics (NASDAQ:VSCP)
(Data available from 7/28/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|3/11/2016||Dawson James||Reiterated Rating||Buy||N/A|
Earnings History for VirtualScopics (NASDAQ:VSCP)Earnings History by Quarter for VirtualScopics (NASDAQ VSCP)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/29/2015||Q315||$0.04||$2.74 million||$3.22 million||View||Listen|
|8/11/2015||Q215||($0.20)||$2.65 million||$3.02 million||View||Listen|
|5/6/2015||Q115||($0.20)||$2.40 million||$2.80 million||View||N/A|
|2/26/2015||Q414||($0.38)||$2.71 million||$2.71 million||View||N/A|
|11/13/2014||Q3 14||($0.33)||$2.74 million||View||N/A|
|5/15/2014||Q1 14||($0.23)||$2.35 million||View||N/A|
|3/7/2014||Q413||($0.35)||$2.60 million||$2.71 million||View||N/A|
|5/15/2013||Q1 2013||($0.04)||$3.70 million||$2.53 million||View||N/A|
Earnings Estimates for VirtualScopics (NASDAQ:VSCP)
Current Year EPS Consensus Estimate: $-0.85 EPS
Dividend History for VirtualScopics (NASDAQ:VSCP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for VirtualScopics (NASDAQ:VSCP)Insider Trades by Quarter for VirtualScopics (NASDAQ:VSCP)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/2/2015||Of Rochester University||Major Shareholder||Sell||33,272||$6.01||$199,964.72|| |
|11/18/2014||Eric Timothy Converse||CEO||Buy||1,400||$3.68||$5,152.00|| |
|9/4/2014||Charles E Phelps||Director||Buy||5,000||$4.60||$23,000.00|| |
|8/28/2014||Eric Timothy Converse||CEO||Buy||12,110||$4.28||$51,830.80|| |
|8/26/2014||Eric Timothy Converse||CEO||Buy||6,000||$4.17||$25,020.00|| |
|8/23/2013||Of Rochester University||Major Shareholder||Sell||88,470||$3.54||$313,183.80|| |
Headline Trends for VirtualScopics (NASDAQ:VSCP)
Latest Headlines for VirtualScopics (NASDAQ:VSCP)
|VirtualScopics (VSCP) Getting Somewhat Favorable Press Coverage, Analysis Finds|
www.americanbankingnews.com - May 3 at 8:08 PM
|Somewhat Positive Media Coverage Very Likely to Affect VirtualScopics (VSCP) Share Price|
www.americanbankingnews.com - April 21 at 7:54 PM
|VirtualScopics, Inc. Board Determines Gastineau Partners Proposal Not Reasonably Expected to Lead to a Superior Company Proposal|
finance.yahoo.com - April 7 at 1:26 PM
|VIRTUALSCOPICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition or|
biz.yahoo.com - May 12 at 1:52 PM
|VirtualScopics (VSCP) Board Says Gastineau Partners Won't Lead to Superior Company Proposal|
www.streetinsider.com - May 10 at 6:18 AM
|Q4 2015 VirtualScopics Inc Earnings Release - Before Market Open|
biz.yahoo.com - March 30 at 7:07 AM
|VirtualScopics Down 11% After BioTelemetry Buyout|
www.benzinga.com - March 28 at 10:19 PM
|VIRTUALSCOPICS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to BioTelemetry, Inc.|
finance.yahoo.com - March 28 at 3:54 PM
|Notable Mergers and Acquisitions 3/28: (HOT) (APO) (VSCP)/(BEAT) (FSNN)|
www.streetinsider.com - March 28 at 2:26 PM
|VirtualScopics Shareholders Should Refuse To Tender Their Shares To BioTelemetry|
seekingalpha.com - March 28 at 2:26 PM
|VIRTUALSCOPICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financ|
biz.yahoo.com - March 25 at 4:35 PM
|VirtualScopics, Inc. Schedules 2015 Fourth Quarter And Full Year Financial Results Press Release, Conference Call And Webcast|
finance.yahoo.com - February 29 at 1:00 PM
|VirtualScopics: A Well-Managed, Small Float Stock On The Edges Of Biotech|
seekingalpha.com - January 28 at 5:33 PM
|VIRTUALSCOPICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen|
biz.yahoo.com - January 22 at 9:16 AM
|9:01 am VirtualScopics to eliminate the marketing exclusivity portion of PPD agreement effective April 11, 2016|
finance.yahoo.com - January 22 at 9:01 AM
|Edited Transcript of VSCP earnings conference call or presentation 29-Oct-15 8:30pm GMT|
finance.yahoo.com - January 6 at 9:28 AM
|VIRTUALSCOPICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits|
biz.yahoo.com - December 21 at 1:06 PM
|VIRTUALSCOPICS, INC. Financials|
finance.yahoo.com - December 8 at 1:18 PM
|VIRTUALSCOPICS, INC. Files SEC form 10-Q, Quarterly Report|
biz.yahoo.com - November 13 at 10:18 AM
|VIRTUALSCOPICS, INC. Files SEC form 8-K, Regulation FD Disclosure|
biz.yahoo.com - November 3 at 8:29 AM
|VIRTUALSCOPICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fin|
biz.yahoo.com - October 29 at 4:31 PM
|Q3 2015 VirtualScopics Inc Earnings Release - 4:00 pm ET|
biz.yahoo.com - October 29 at 7:07 AM
|VirtualScopics, Inc. to Host Third Quarter 2015 Earnings Conference Call and Webcast Live on Thursday, October 29, 2015|
finance.yahoo.com - October 28 at 4:15 PM
VirtualScopics (VSCP) Chart for Friday, July, 28, 2017